CLYM Climb Bio

• $780K bought by 1 insider
• None no sales outside a trading plan
• $2.2M sold by 1 insider under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Stephen Basil Thomas Director
   Planned sale
   $1.4M 100,000 shares at $13.67 18% of stake
   Traded Sep 15 Filed Sep 17
   ↗
3. Stephen Basil Thomas Director
   Planned sale
   $350K 50,000 shares at $7.01 24% of stake
   Traded Feb 25–26 Filed Feb 27
   ↗
4. Stephen Basil Thomas Director
   Planned sale
   $529K 100,000 shares at $5.29 33% of stake
   Traded Feb 12–13 Filed Feb 17
   ↗
5. Ra Capital Management, L.P. Director, +6 joint filers
   Buy
   $25K 7,111 shares at $3.50 +0.2% to stake
   Traded Jan 5 Filed Jan 7
   ↗
6. Ra Capital Management, L.P. Director, +6 joint filers
   Buy
   $755K 314,561 shares at $2.40 +10% to stake
   Traded Dec 11–12 Filed Dec 15, 2025
   ↗

Also filed in the last 12 months, not counted as buying or selling: 5 option exercises, 1 sale back to the company, and 1 sale to cover taxes.